Related references
Note: Only part of the references are listed.Protective effect of vascular endothelial growth factor against cardiopulmonary bypass-associated acute kidney injury in beagles
Yiping Bai et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
VEGF-A165b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF-A splice isoforms from the kidney
Megan Stevens et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease
Jennifer Batson et al.
ACS CHEMICAL BIOLOGY (2017)
Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease
Omar C. Logue et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
Alternative mRNA transcription, processing, and translation: insights from RNA sequencing
Eleonora de Klerk et al.
TRENDS IN GENETICS (2015)
Vascular Endothelial Growth Factor-A(165)b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy
Sebastian Oltean et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Alternative splicing in cancer: implications for biology and therapy
J. Chen et al.
ONCOGENE (2015)
Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer
A. Mavrou et al.
ONCOGENE (2015)
Integrative Biology Identifies Shared Transcriptional Networks in CKD
Sebastian Martini et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Context-dependent control of alternative splicing by RNA-binding proteins
Xiang-Dong Fu et al.
NATURE REVIEWS GENETICS (2014)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
The alternative splicing side of cancer
Giuseppe Biamonti et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Regulation of splicing by SR proteins and SR protein-specific kinases
Zhihong Zhou et al.
CHROMOSOMA (2013)
SRPK1 Inhibition Modulates VEGF Splicing to Reduce Pathological Neovascularization in a Rat Model of Retinopathy of Prematurity
Melissa V. R. Gammons et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
The Evolutionary Landscape of Alternative Splicing in Vertebrate Species
Nuno L. Barbosa-Morais et al.
SCIENCE (2012)
The role of VEGF165b in pathophysiology
Maria Peiris-Pages
CELL ADHESION & MIGRATION (2012)
VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult mice
Sebastian Oltean et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Elianna M. Amin et al.
CANCER CELL (2011)
Spliceosome Structure and Function
Cindy L. Will et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Induction of Podocyte VEGF164 Overexpression at Different Stages of Development Causes Congenital Nephrosis or Steroid-Resistant Nephrotic Syndrome
Delma Veron et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Functional diversity of the hnRNPs: past, present and perspectives
Siew Ping Han et al.
BIOCHEMICAL JOURNAL (2010)
Overexpression of VEGF165b in Podocytes Reduces Glomerular Permeability
Yan Qiu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease
Delma Veron et al.
KIDNEY INTERNATIONAL (2010)
Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity
Harukiyo Kawamura et al.
CANCER RESEARCH (2008)
Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors
Dawid G. Nowak et al.
JOURNAL OF CELL SCIENCE (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
Qun Pan et al.
NATURE GENETICS (2008)
The Alternatively Spliced Anti-Angiogenic Family of VEGF Isoforms VEGF(xxx)b in Human Kidney Development
Heather S. Bevan et al.
NEPHRON PHYSIOLOGY (2008)
VEGF inhibition and renal thrombotic microangiopathy
Vera Eremina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome
Valerie Anne Schumacher et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Role of the VEGF-A signaling pathway in the glomerulus: Evidence for crosstalk between components of the glomerular filtration barrier
Vera Eremina et al.
NEPHRON PHYSIOLOGY (2007)
Understanding alternative splicing: Towards a cellular code
AJ Matlin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein
TG Cui et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Share Paper
